LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK)

HKD 17.56

(0.34%)

Market Cap (In HKD)

6.08 Billion

Revenue (In HKD)

325.89 Million

Net Income (In HKD)

151.53 Million

Avg. Volume

135.88 Thousand

Currency
HKD
Country
Open
-
Prev. Close
-
Day Range
-
Year Range
13.0-29.8
PE
-
EPS
-
Beta Value
-0.651
ISIN
CNE1000057M5
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industry
CEO
Ms. Juan Chen
Employee Count
-
Website
https://www.scientechmed.com
Ipo Date
2022-11-08
Details
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occluder products; treatment of valvular disease solutions comprising aortic valve products, mitral valve products, tricuspid valve products, pulmonary valve products, and procedural accessories; and vascular plugs and interatrial shunt devices. The company offers its products primarily to distributors and hospitals. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. is a subsidiary of Lepu Medical Technology (Beijing) Co., Ltd.